The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ctDNA analysis for personalization of consolidation immunotherapy in localized non-small cell lung cancer.
 
Everett J Moding
No Relationships to Disclose
 
Yufei Liu
No Relationships to Disclose
 
Barzin Nabet
No Relationships to Disclose
 
Jacob J. Chabon
Consulting or Advisory Role - Lexent Bio
 
Aadel Chaudhuri
Stock and Other Ownership Interests - Celgene; Merck
Honoraria - Foundation Medicine; Roche; Varian Medical Systems
Consulting or Advisory Role - Geneoscopy; Roche
Patents, Royalties, Other Intellectual Property - US Patent No. US 8,685,727 B2, issued 4/1/14: Regulation of macrophage activation using miR-125b
Other Relationship - Roche
 
Angela B. Hui
No Relationships to Disclose
 
Jianzhong He
No Relationships to Disclose
 
Yawei Qiao
No Relationships to Disclose
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Genentech; GlaxoSmithKline; Guardant Health; Hengrui Pharmaceutical; Merck; Novartis; Spectrum Pharmaceuticals
Research Funding - AstraZeneca (Inst); Spectrum Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations
 
Anne S. Tsao
Consulting or Advisory Role - ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Epizyme; Genentech/Roche; HERON; Imedex; Lilly; MedImmune; Novartis; Takeda
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); MedImmune (Inst); Merck (Inst); Millennium; Polaris; Seagen
Patents, Royalties, Other Intellectual Property - UptoDate
 
Zhongxing X. Liao
Honoraria - Varian Medical Systems
Speakers' Bureau - Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems
 
Daniel Richard Gomez
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Merck
 
Kavitha Ramchandran
No Relationships to Disclose
 
Joel W. Neal
Consulting or Advisory Role - ARIAD/Takeda; AstraZeneca; Exelixis; Genentech/Roche; Jounce Therapeutics; Lilly; Loxo
Research Funding - ARIAD/Takeda (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst)
 
Heather A. Wakelee
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - AstraZeneca
Research Funding - ACEA Biosciences (Inst); Arrys Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Billy W. Loo
Stock and Other Ownership Interests - TibaRay, Inc.
Honoraria - Varian Medical Systems
Research Funding - RaySearch Laboratories; Varian Medical Systems
 
Steven H. Lin
Honoraria - AstraZeneca/MedImmune
Speakers' Bureau - Varian Medical Systems
Research Funding - Genentech/Roche; Hitachi Chemical; New River Labs; STCube Pharmaceuticals Inc.
 
Ash A. Alizadeh
Leadership - Lymphoma Research Foundation
Stock and Other Ownership Interests - CAPP Medical; CiberMed; Forty Seven
Honoraria - Janssen Oncology; Janssen Oncology; Roche
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche/Genentech
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University. (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Maximilian Diehn
Stock and Other Ownership Interests - CiberMed
Consulting or Advisory Role - Roche
Research Funding - Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Travel, Accommodations, Expenses - Roche; Varian Medical Systems